A list of underlying medical conditions for HSCT treatment of autoimmune diseases

Webinar records with PhD, MD, Dr. Denis Fedorenko

Intermediate-Intensity Chemotherapy (IDCT) + AHSCT for patients with Relapsing-Remitting Multiple Sclerosis (RRMS)

Indications and Efficacy of Disease-Modifying Therapies and Supportive Care of Multiple Sclerosis

Research Article: Acta Scientific Neurology (ASNE) Volume 8 Issue 11 November 2025

Comparison of HSCT treatment protocols available to foreign citizens